Chemerin and Polycystic Ovary Syndrome: A Comprehensive Review of Its Role as a Biomarker and Therapeutic Target
<b>Background:</b> Chemerin, an adipokine implicated in inflammatory, metabolic, and adipogenic processes, has been detected in high serum concentration in women with polycystic ovary syndrome (PCOS) and seems to play a role in PCOS pathogenesis. Moreover, at present, no comprehensive an...
Saved in:
| Main Authors: | Stefano Palomba, Giuseppe Seminara, Flavia Costanzi, Donatella Caserta, Antonio Aversa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/12/12/2859 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polycystic ovary syndrome - 80 years of research and new directions in the study (literature review)
by: L. V. Damdinova, et al.
Published: (2016-09-01) -
Impact of polycystic ovary syndrome on the atherogenic plasma index: A retrospective analysis
by: Huseyin Demirci, et al.
Published: (2025-07-01) -
Comprehensive Management of Polycystic Ovary Syndrome: The Role of Metformin in Addressing Metabolic and Endocrine Dysregulation
by: Martyna Kaźmierczak, et al.
Published: (2025-01-01) -
Polycystic Ovary Syndrome - treatment update
by: Marta Szymura, et al.
Published: (2025-07-01) -
SCLEROCYSTIC OVARIES: CURRENT APPROACHES TO THE PROBLEM
by: A. G. Solopova, et al.
Published: (2017-08-01)